DJ Abbott Laboratories Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Abbott Laboratories $(ABT.AU)$ slid 1.84% to $126.19 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.37% to 6,339.39 and Dow Jones Industrial Average falling 0.74% to 44,130.98.
The stock's fall snapped a two-day winning streak.
Abbott Laboratories closed 10.65% below its 52-week high of $141.23, which the company achieved on March 4th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 1.51% to $164.74, Pfizer Inc. $(PFE.AU)$ fell 2.18% to $23.29, and Merck & Co. Inc. $(MRK.UK)$ fell 4.44% to $78.12.
Trading volume (6.7 M) remained 80,714 below its 50-day average volume of 6.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 31, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
July 31, 2025 16:33 ET (20:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Comments